APOE and Alzheimer disease: Given the effectiveness of the amylin class of peptides in reducing amyloid pathology in the brain in the preclinical study and the relationship between amylin and Aβ in the context of ApoE allele seen in this human study, pramlintide may have potential as a treatment in AD.